Blood lipid and lipoprotein levels and the risk of cancer of the colon and rectum - A prospective study of 62,173 Norwegian men and women

被引:24
作者
Gaard, M [1 ]
Tretli, S [1 ]
Urdal, P [1 ]
机构
[1] ULLEVAL HOSP,DEPT CLIN CHEM,OSLO,NORWAY
关键词
cholesterol; colon cancer; lipoproteins; Norway; rectal cancer;
D O I
10.3109/00365529709000187
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Concern has been raised that a low total serum cholesterol level, although beneficial for cardiovascular diseases, may increase the risk of cancer. This prospective cohort study analyses the hypotheses that a low total serum cholesterol level or its subfractions (serum low-density-lipoprotein cholesterol, high-density-lipoprotein cholesterol, and triglycerides) increase the risk of cancer of the colon and rectum. Methods: Between 1977 and 1983, 62,173 men and women attended a health screening carried out by the Norwegian National Health Screening Service. The screening consisted of a questionnaire, anthropometric measurements, and samples of non-fasting blood drawn far analyses of serum total cholesterol, low-density-lipoprotein cholesterol, high-density-lipoprotein cholesterol, and triglycerides. Results: During the 7- to 13-year follow-up, 186 patients were found to have colon cancer and 106 rectal cancer by linkage to the Norwegian Cancer Registry. Among men there were no associations between blood lipid and lipoprotein levels and risk of cancer of the proximal colon, distal colon, or the rectum. Among women there was a formal statistically significant inverse relationship between level of total cholesterol and low-density-lipoprotein cholesterol and risk of distal colon cancer, and a positive trend between total cholesterol level and rectal cancer. Conclusions: The statistically significant results among women were interpreted as incidental, and we conclude that blood lipid and lipoprotein levels were not associated with the risk of colon or rectum cancer in men or women in this cohort.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 28 条
[1]  
ANDERSON DE, 1982, CANCER EPIDEMIOL, P483
[2]  
[Anonymous], 1989, Diet and health: implications for reducing chronic disease risk
[3]  
Bjartveit K, 1979, Acta Med Scand Suppl, V634, P1
[4]  
BURSTEIN M, 1970, J LIPID RES, V11, P583
[5]   PROSPECTIVE-STUDY OF SERUM-CHOLESTEROL AND SITE-SPECIFIC CANCERS [J].
CHYOU, PH ;
NOMURA, AMY ;
STEMMERMANN, GN ;
KATO, I .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (03) :287-292
[6]   CANCER MORTALITY AND LIPID AND LIPOPROTEIN LEVELS - THE LIPID RESEARCH CLINICS PROGRAM MORTALITY FOLLOW-UP-STUDY [J].
COWAN, LD ;
OCONNELL, DL ;
CRIQUI, MH ;
BARRETTCONNOR, E ;
BUSH, TL ;
WALLACE, RB .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1990, 131 (03) :468-482
[7]   EINE NEUE BESTIMMUNG DER NEUTRALFETTE IM BLUTSERUM UND GEWEBE .I. PRINZIP DURCHFUHRUNG UND BESPRECHUNG DER METHODE [J].
EGGSTEIN, M ;
KREUTZ, FH .
KLINISCHE WOCHENSCHRIFT, 1966, 44 (05) :262-&
[8]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[9]  
HILL MJ, 1994, EPIDEMIOLOGY DIET CA, P10
[10]   CHANGES IN LIPOPROTEIN COMPOSITION DURING THE MENSTRUAL-CYCLE [J].
KIM, HJ ;
KALKHOFF, RK .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1979, 28 (06) :663-668